Conceptio › Archive › ClinicalTrials.gov
ClinicalTrials.govpublic full text

A Study Combining Eribulin Mesylate With Avelumab in Cisplatin Ineligible Metastatic Urothelial Cell Cancer Patients

Monika Joshi, MD · 2018
ClinicalTrials.gov · Datasets · License: Public Domain · 2018
Open Source ↗
metastatic urothelial cell cancer, cisplatin-ineligible, avelumab, pd-l1 monoclonal antibody, eribulin mesylate, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 889313
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.